Latvia's Paula Stradins Clinical University Hospital has received accreditation from the European Federation of Immunogenetics, enabling it to join the Nordic organ exchange network, Scandiatransplant.
Latvia's Paula Stradins Clinical University Hospital (PSKUS) has achieved accreditation from the European Federation of Immunogenetics (EFI) which is a crucial requirement for the country to join the Nordic organ exchange network known as Scandiatransplant. This accreditation signifies that the immunogenetic testing conducted at Stradiņa Hospital's Joint Laboratory meets the highest international quality standards essential for safe organ compatibility assessments during the transplantation process.
According to Vineta Kļaviņa, head of the hospital's Public Relations Department, this certification is mandatory for any country wishing to participate in the shared Nordic organ exchange system. Being part of this international transplantation network becomes possible only if the national laboratory has obtained the EFI accreditation, which places Latvia in line with European standards for organ transplant procedures.
Dagnija Straupmane, head of the Joint Laboratory at Stradiņa Hospital, emphasizes that achieving this accreditation means that analyses in Latvia are conducted at a level comparable to leading European transplant centers. It highlights Latvia’s commitment to improving its healthcare and transplantation services, enhancing the prospects for patients in need of organ transplants.
